Facebook
Twitter
LinkedIn
ForwardPerioperative Cardiac Risk Management (2018-2021) No CME Available
Steven L. Cohn, MD, MACP, SFHM
If you are a Program Director and would like to grant access to your trainees, please reach out to education@hospitalmedicine.org for an academic access code.
SUMMARY
Perioperative cardiac complications are the most widely feared medical issues for the anesthesiologist, surgeon, and medical consultant as they approach a patient in the perioperative period. Only recently have management strategies been addressed in high-quality studies. The following module explains the roles of medical and interventional treatments in lowering perioperative cardiac event rates. This module also discusses the typical presentation of coronary syndromes postoperatively and the management of antiplatelet and cardiac medications.
GOAL
To provide hospitalists with current management strategies to reduce the risk of perioperative cardiac events.
TARGET AUDIENCE
This activity is designed for hospitalists. No prerequisites required.
LEARNING OBJECTIVES
After participating in this module, the participant will demonstrate the ability to:
- Analyze the evidence for beta-blocker therapy in the management of patients at elevated perioperative risk for cardiac events.
- Assess the role for statins in perioperative cardiac risk reduction.
- Discuss the importance of continuing cardiac medications in the perioperative setting and the role of clonidine, aspirin, and nitrates in reducing perioperative cardiac risk.
- Evaluate the role for coronary interventions in preoperative patients with documented ischemia on noninvasive cardiac testing.
- Discuss the perioperative management of antiplatelet therapy for patients with cardiac stents.
- Elucidate the typical presentation of postoperative myocardial infarctions and realize the utility of screening measures.
ACCREDITATION STATEMENTS
The American Osteopathic Association (AOA) has approved this activity of the Society of Hospital Medicine for 2 AOA Category 2-B CME credits.
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CONFLICT OF INTEREST DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.
Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.
Additional Information
| Attachment | Size |
|---|---|
 References for Perioperative Cardiac Risk Management | 559.97 KB |
FACULTY & DISCLOSURES
Author
Steven L. Cohn, MD, MACP, SFHM
Director–Medical Consultation Service
Jackson Memorial Hospital
Professor Emeritus
Department of Medicine
University of Miami – Miller School of Medicine,
Miami, Florida
Dr. Cohn reports having minor stock holdings in AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Merck & Co, Inc, Pfizer Inc, and Portola; and serving on the Speakers Bureau for Janssen and Portola.
Editors
Leonard Feldman, MD, FACP, SFHM
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Urban Health Residency and Track Director
Associate Program Director, Osler Medical Residency
Director, Comprehensive General Medicine Consult Service
Founding Editor-in-Chief, Consultative & Perioperative Medicine Essentials for Hospitalists
Baltimore, Maryland
Dr. Feldman reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
Kurt Pfeifer, MD, FACP, SFHM
Professor of Medicine
General Internal Medicine
Medical Director, Froedtert and Medical College of Wisconsin Eye Institute Perioperative Services
Medical College of Wisconsin
Associate Editor-in-Chief, Consultative & Perioperative Medicine Essentials for Hospitalists
Milwaukee, Wisconsin
Dr. Pfeifer reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
REFERENCE DISCLOSURE
Please note, there is an ongoing inquiry into publications involving Dr Poldermans and his colleagues. The results of this inquiry may affect recommendations regarding perioperative use of β-blockers and statins.
OFF-LABEL PRODUCT DISCUSSION
All faculty have indicated that they have not referenced unlabeled or unapproved uses of drugs or devices.
DISCLAIMER
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
SHM CONFLICT OF INTEREST DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.
Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.
ACCREDITATION STATEMENT
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Price
Click START to begin.
If you are a Program Director and would like to grant access to your trainees, please reach out to education@hospitalmedicine.org for an academic access code.